Abstract
Urticaria has diverse clinical presentations and causes. It is one of the most frequent dermatological conditions: 15% to 20% of population has at least one acute eruption during their lifetime, resulting in 1% to 2% of dermatological and allergological visits. Urticaria is classified based on its temporal evolution as acute (less than 6 weeks) or chronic (more than 6 weeks). Management strategies may involve non-pharmacological measures and drug interventions, which are grouped into first- (antihistamines), second- (corticosteroids and anti-leukotrienes) and third-line therapies (immunomodulators). Stronger, but potentially riskier, second- and third-line management may be justified for patients who do not respond to first-line therapy, or whenever a specific etiology cannot be determined, such as in autoimmune urticaria. © 2005 by Anais Brasileiros de Dermatologia.
Author supplied keywords
Cite
CITATION STYLE
Criado, P. R., Costa Martins, J. E., Jardim Criado, R. F., Rivitti, E. A., & Maruta, C. W. (2005). Urticaria. Anais Brasileiros de Dermatologia. Sociedade Brasileira de Dermatologia. https://doi.org/10.1590/s0365-05962005000700008
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.